Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

por Zuiverloon, Tahlita C.M., de Jong, Florus C., Costello, James C., Theodorescu, Dan
Publicado 2018

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy

por Scholtes, Mathijs P., de Jong, Florus C., Zuiverloon, Tahlita C. M., Theodorescu, Dan
Publicado 2021

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

por de Jong, Florus C., Rutten, Vera C., Zuiverloon, Tahlita C. M., Theodorescu, Dan
Publicado 2021

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?

por de Jong, Florus C., GeurtsvanKessel, Corine H., Molenkamp, Richard, Bangma, Chris H., Zuiverloon, Tahlita C.M.
Publicado 2023

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)

por Tu, Megan M., Ng, Terry L., De Jong, Florus C., Zuiverloon, Tahlita C.M., Fazzari, Francesco G.T., Theodorescu, Dan
Publicado 2019

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

por Rinaldetti, Sébastien, Zhou, Qiong, Abbott, Joshua M., de Jong, Florus C., Esquer, Hector, Costello, James C., Theodorescu, Dan, LaBarbera, Daniel V.
Publicado 2022